Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer - Quiz - MDSpire

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer

  • By

  • Jingjing Chen

  • Qiaoli Wang

  • Junmeng Zhu

  • Xinyuan Bai

  • Haochen Tang

  • Xiang Kong

  • Lu Zou

  • Qinghua Zheng

  • Yingxin Wang

  • Yan Zhao

  • Baorui Liu

  • Fanyan Meng

  • Juan Du

  • June 29, 2026

  • 0 min

Share

Original Source(s)

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer

  • by Jingjing Chen, Qiaoli Wang, Junmeng Zhu, Xinyuan Bai, Haochen Tang, Xiang Kong, Lu Zou, Qinghua Zheng, Yingxin Wang, Yan Zhao, Baorui Liu, Fanyan Meng, Juan Du

  • June 29, 2026

Related Content

Network analysis of distress, symptom burden, social support, and digital health literacy in older postoperative patients with gastric cancer

Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression

Aerobic exercise training attenuates the deleterious effects of walker-256 cancer: effects on physical capacity, cachexia, and cardiac mass